ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cassava To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cassava between February 7, 2024 and November 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh […]

Ryoncil(R) Commercial Launch Update and Product Pipeline

(AUST:MSB.AX),(NASDAQ:MESO), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the progress of the U.S. commercial launch of Ryoncil(R) (remestemcel-L) for steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients 2 months and older and key upcoming milestones for

Postal Realty Trust Declares Fourth Quarter 2024 Dividend

(NYSE:PSTL), – Increases Dividend for Seventh Consecutive Year – – Provides Tax Characteristics of 2024 Dividends – CEDARHURST, N.Y., Jan. 30, 2025 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,000 properties leased primarily to the United States Postal Service

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) WilsonEncourages Investors Who Suffered Losses In Kyverna To Contact Him Directly To Discuss Their Options If you purchased or acquired securities investing Kyverna common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Innovative Industrial Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action — IIPR

(NYSE:IIPR), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innovative Industrial Properties, Inc. (NYSE: IIPR) between February 27, 2024 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline. SO WHAT:

New Black History Month stamp features Marie Joseph Angélique

Accused of a crime she denied doing, Angélique's story sheds light on the history of – and resistance to – enslavement in what is now Canada Canada Post today unveiled its 2025 Black History Month stamp featuring Marie Joseph Angélique. Her harrowing story reminds us of the history of enslavement in what is now Canada

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Block, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SQ, XYZ

(NYSE:SQ),(NYSE:XYZ), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Block, Inc. (NYSE: SQ, XYZ) between February 26, 2020 and April 30, 2024, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline.

Metsera Announces Pricing of Initial Public Offering

(NASDAQ:MTSR), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, overweight and related conditions, today announced the pricing of its initial public offering of 15,277,778 shares of its common stock at a price

ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN

(NASDAQ:AZN), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the “Class Period”), of the February 21, 2025 lead plaintiff deadline in the securities class action

Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – KYTX

NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=126162&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top